No Data
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'The Patent Covers a Broader Range of Genotype Combinations Identified by the Company's Proprietary Genetic Diagnostic for Targeted Treatment of Alcohol Use Disorder (AUD) With AD04'
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Granted Key U.S. Patent For The Treatment Of Alcohol And Drug Dependence Based On Expanded Genotype Combinations
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know
Adial Pharmaceuticals Advances AD04 With Promising Study Results
Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
No Data
No Data